Acquisitions and License Agreements (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Millions		Jun. 24, 2016	Feb. 01, 2016	Sep. 25, 2015	Apr. 16, 2015
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Goodwill		$ 3,645.5		$ 3,649.4
Hemostasis Products
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Cash and cash equivalents			$ 3.3
Inventory			94.6
Intangible assets			132.7
Goodwill			0.3
Other assets, current and non-current	[1]		7.9
Total assets acquired			238.8
Current liabilities			7.4
Other liabilities (non-current)			10.6
Deferred tax liabilities, net (non-current)			(4.7)
Contingent consideration			52.0
Long-term Debt			0.0
Total liabilities assumed			65.3
Net assets acquired			173.5
Acquired accounts receivable			$ 0.0
Therakos
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Cash and cash equivalents				41.3
Inventory				23.5
Intangible assets				1,170.0
Goodwill				430.4
Other assets, current and non-current	[1]			42.1
Total assets acquired				1,707.3
Current liabilities				24.7
Other liabilities (non-current)				0.6
Deferred tax liabilities, net (non-current)				318.1
Contingent consideration				0.0
Long-term Debt				344.8
Total liabilities assumed				688.2
Net assets acquired				1,019.1
Acquired accounts receivable				$ 22.0
Ikaria, Inc.
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Cash and cash equivalents					$ 77.3
Inventory					26.3
Intangible assets					1,971.0
Goodwill					795.0
Other assets, current and non-current	[1]				174.3
Total assets acquired					3,043.9
Current liabilities					33.0
Other liabilities (non-current)					15.8
Deferred tax liabilities, net (non-current)					620.5
Contingent consideration					0.0
Long-term Debt					1,121.0
Total liabilities assumed					1,790.3
Net assets acquired					1,253.6
Acquired accounts receivable					$ 73.8

[1] This amount includes zero, $22.0 million and $73.8 million, of accounts receivable for the Hemostasis Acquisition, Therakos Acquisition and the Ikaria Acquisition, respectively, which is also the gross contractual value.